Search This Blog

Friday, September 5, 2025

REGENXBIO reports positive data from Hunter syndrome (RGNX)

 REGENXBIO's gene therapy for Hunter syndrome, showed 82% efficacy and strong safety in trials.

https://seekingalpha.com/news/4492725-regenxbio-reports-positive-data-from-hunter-syndrome

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.